Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pacific Biosciences of California Inc shares valued at $5,200 were sold by Farmer Michele on May 19 ’25. At $1.00 per share, Farmer Michele sold 5,195 shares. The insider’s holdings dropped to 269,259 shares worth approximately $0.28 million following the completion of this transaction.
Also, HENRY CHRISTIAN O sold 12,497 shares, netting a total of over 17,583 in proceeds. Following the sale of shares at $1.41 each, the insider now holds 2,225,357 shares.
Before that, Van Oene Mark had sold 6,486 shares from its account. In a trade valued at $9,126, the insider traded Pacific Biosciences of California Inc shares for $1.41 each. Upon closing the transaction, the insider’s holdings decreased to 6,486 shares, worth approximately $1.56 million.
As published in a research note from UBS on November 11, 2024, Pacific Biosciences of California Inc [PACB] has been rated down from a Buy to a Neutral. As of April 22, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for PACB. Earlier on April 18, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for PACB stock which previously was a “a Buy”.
Analyzing PACB Stock Performance
During the last five days, there has been a surge of approximately 5.99%. Over the course of the year, Pacific Biosciences of California Inc shares have dropped approximately -43.17%. Shares of the company reached a 52-week high of $2.2200 on 01/08/25 and a 52-week low of $0.8500 on 05/28/25.
Support And Resistance Levels for Pacific Biosciences of California Inc (PACB)
According to the 24-hour chart, there is a support level at 0.9967, which, if violated, would cause prices to drop to 0.9533. In the upper region, resistance lies at 1.1167. The next price resistance is at 1.1933. RSI (Relative Strength Index) is 46.48 on the 14-day chart, showing neutral technical sentiment.
